Generally Covered: Diabetes indication with documented A1C elevation Generally Not Covered: Obesity alone without diabetes or other qualifying conditions Private Insurance: Coverage varies widely by plan, some cover weight management medications Research Peptides: Not covered by any provincial plan or private insurance (personal expense) Regional Access to Research Peptides Domestic Canadian shipping eliminates regional access disparities for research peptides
Retatrutide does not have a legitimate monthly retail price because it is investigational, not FDA-approved, and not commercially available
Wegovy can cause gastrointestinal issues when going to the bathroom, gas, bloating, nausea, and acid reflux
Start your intake Approved Tirzepatide Injection Sites for Weight Loss The FDA-approved tirzepatide injection sites include the abdomen, upper arm, and thigh
Inspectors found compounded drug products used bulk drug substance from a source that is not an FDA-registered establishment